Rebecca E Dombrowski
Visit Investigator ProfileInvestigation Details
Ileana Barreto-Pettit , Kejun Cheng , Zip Dusta , Robert M Barbosa , Ann Raju Daniel , Alison N Stieg , Martha Sullivan Myrick , Emily J Orban , Marcus A Ray , Patsy J Domingo , Sarah M Napier , Tracey L Taylor , Emily Dorlon , L'Oreal D Fowlkes , Atul Agrawal , Caroline H Le , Larry K Austin , Ko U Min , Farhana Khan , Daniel J Brown , Regina T Brown , Andrew J Idzior , Andrea F White , Monica C Burgos Garcia , Russell K Riley , Melissa T Roy , James M Mason
Detailed Analysis
Investigator Rebecca E Dombrowski approach leans towards a strict audit, often focusing methodically on quality control, lab controls, process control, and clean equipment. Her methods indicate a deep level of knowledge in pharmaceutical drug manufacturing and has a particular interest in ensuring compliance with all written procedures.
Rebecca E Dombrowski is a diligent FDA investigator with a high interest in ensuring strict adherence to quality control units, well-established procedures, equipment cleanliness, and the purity of drug products. She often focuses on laboratory controls, equipment usage and maintenance, and batch record review. Her profile suggests a strong emphasis on detail-oriented scrutiny and a thorough understanding of the requirements in pharmaceutical manufacturing environments.
Unlock Insights from 483s & Stay Audit Ready with FDA Tracker
Monitor FDA Six Systems, Analyse 483s with Observations, Investigators & Companies
